It was honor to be invited as volunteer of a UK based organization GSK by H.E Mr. Denis Keefe the ambassador of United Kingdom to Serbia on cocktail arranged at his residence in showing gratitude towards the noble services of GSK towards Serbian community. H.E warmly welcomed, greeted and acknowledged the corporate social responsibility actions of GSK, especially the opportunities of volunteering provided to employees in making healthy communities.
I was privileged by my first appearance with distinguished diplomatic missions in Serbia, the chairman of BELhospice honorary patron`s committee (the ambassador of Belgium) and GSK colleagues from all the fields including medical, marketing and sales.
I was honorary guest being part of family from GSK, however Ivana Todorovic and Zoran Purkovic from BELhospice (where I am deployed) also attended the event as our partner NGO for PULSE program in Serbia.
GSK Serbia and Montenegro launched their Corporate Social Responsibility Report during this event held on October 1st at the residence of the Ambassador of Great Britain in Belgrade.
H.E Mr. Denis Keefe the Ambassador said: “One of the priorities of the British government is to achieve sustainable and balanced economic development throughout the country and to build a stronger and more just society. One of the key components of such a society is responsible business. GSK is a company that has been awarded with as many as five awards in just three years in the field of corporate responsibility in Serbia for its support to patients, the local community and for the creation of a supportive work environment.”
Addressing the representatives of state institutions, healthcare and non-governmental sectors, Milutin Delic, GM GSK Serbia, Montenegro, Macedonia, Bosnia & Herzegovina and Albania said: “One of the reasons I assumed the role of GM for GSK in Serbia was because of the value that the company brings to society. I’m proud that I have had the opportunity to see a number of changes which have helped the company progress, whether it be on efforts to improve access to our medicines, continuous investment in the community or the evolution of the operating model towards a structure that is better integrated into the local environment.”